NicSnap1 inhibitors are a class of chemical compounds that interact with the NicSnap1 protein, a crucial component in cellular signaling pathways. These inhibitors are known for their ability to modulate specific biochemical interactions by selectively binding to the NicSnap1 protein, leading to a reduction in its activity. This modulation affects downstream pathways associated with various intracellular processes, including protein synthesis, cellular stress responses, and energy metabolism. The molecular structure of NicSnap1 inhibitors typically includes diverse chemical scaffolds that allow for a high degree of specificity in targeting NicSnap1. These compounds are designed to maintain strong binding affinity to the NicSnap1 active site, which is often facilitated by hydrophobic interactions, hydrogen bonding, and van der Waals forces, depending on the specific inhibitor's architecture.
NicSnap1 inhibitors can exhibit varied physicochemical properties, such as differing solubility, stability, and permeability, which can be fine-tuned during the development process. Researchers often investigate these properties to ensure the inhibitors perform well in controlled laboratory environments, particularly in experiments involving biochemical assays and protein interaction studies. The development of NicSnap1 inhibitors typically focuses on optimizing key parameters such as binding selectivity and minimization of off-target effects to better understand the mechanistic pathways of NicSnap1. Their distinct molecular makeup provides an important tool for studying the functional role of NicSnap1 in various biological processes, enabling detailed investigations into the protein's structural and functional dynamics in cellular systems.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | ¥1083.00 ¥2821.00 ¥8462.00 ¥16111.00 | 280 | |
抑制 V-ATP 酶,可能会影响囊泡的贩运和神经递质的释放。 | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | ¥2933.00 ¥9014.00 | 36 | |
破坏肌动蛋白聚合,可能影响突触囊泡动力学和神经元的完整性。 | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | ¥745.00 ¥2471.00 ¥4705.00 | 97 | |
PI3K 抑制剂可能会影响细胞存活和突触功能的信号通路。 | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | ¥1094.00 ¥2866.00 | 36 | |
抑制蛋白质合成,可能影响神经元功能和突触可塑性。 | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | ¥2008.00 | 25 | |
抑制 CaMKII,可能会影响钙信号传导和突触强度。 | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | ¥440.00 ¥1015.00 | 212 | |
MEK 抑制剂可能会影响参与突触可塑性和记忆形成的 MAPK/ERK 通路。 | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | ¥857.00 ¥1670.00 | 9 | |
抑制钙神经蛋白,可能会影响 T 细胞活化和神经炎症。 | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | ¥1365.00 ¥4423.00 | 148 | |
抑制 PI3K,可影响参与细胞生长和存活的各种信号通路。 | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | ¥699.00 ¥1015.00 ¥3373.00 ¥5359.00 ¥11451.00 ¥23681.00 | 69 | |
钙神经蛋白抑制剂,可调节免疫反应和神经保护。 | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | ¥993.00 ¥3858.00 | 284 | |
p38 MAPK 抑制剂可影响炎症反应和细胞应激途径。 |